Filing Details

Accession Number:
0000950170-23-068922
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-12-08 08:00:05
Reporting Period:
2023-12-07
Accepted Time:
2023-12-08 08:00:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1833214 Sab Biotherapeutics Inc. SABS Biological Products, (No Disgnostic Substances) (2836) 853899721
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1889712 Joe Eddie Sullivan 2100 E 54Th Street North
Sioux Falls SD 57104
Chief Executive Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-12-07 1,740 $0.88 5,232,304 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Represents 1,740 shares of the Issuer's common stock, par value $0.0001 per share, acquired by the reporting person in an open market transaction.